---
title: "輝瑞提起訴訟，旨在阻止諾和諾德競購肥胖症藥企 Metsera"
description: "輝瑞公司已對 Metsera Inc.與諾和諾德公司提起訴訟，旨在阻止諾和諾德對 Metsera 的收購。輝瑞要求美國特拉華州法院阻止交易，以便獲得聽證。輝瑞認為諾和諾德的報價不符合 “更優公司提案” 的條件。同時，美國反壟斷執法機構已批准輝瑞繼續推進對 Metsera 的收購要約。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/263813901.md"
published_at: "2025-10-31T22:32:13.000Z"
---

# 輝瑞提起訴訟，旨在阻止諾和諾德競購肥胖症藥企 Metsera

> 輝瑞公司已對 Metsera Inc.與諾和諾德公司提起訴訟，旨在阻止諾和諾德對 Metsera 的收購。輝瑞要求美國特拉華州法院阻止交易，以便獲得聽證。輝瑞認為諾和諾德的報價不符合 “更優公司提案” 的條件。同時，美國反壟斷執法機構已批准輝瑞繼續推進對 Metsera 的收購要約。

輝瑞公司已起訴 Metsera Inc.與諾和諾德公司，希望能阻止諾和諾德對這家新興肥胖症藥企發起的競爭性收購。輝瑞正要求美國特拉華州衡平法院阻止 Metsera 與諾和諾德完成交易，以便給輝瑞時間獲得聽證。輝瑞表示，根據合併協議，諾和諾德的報價不符合 “更優公司提案（Superior Company Proposal）” 的條件。輝瑞宣佈，美國反壟斷執法機構已批准其繼續推進對 Metsera 的收購要約，稱《哈特 - 斯科特 - 羅迪諾反壟斷改進法案》規定的等待期終止 “滿足了擬議收購下的監管審查要求”。

### Related Stocks

- [PFE.US - 輝瑞](https://longbridge.com/zh-HK/quote/PFE.US.md)
- [NVO.US - 諾和諾德公司](https://longbridge.com/zh-HK/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Puzo Michael J Has $320,000 Stock Position in Novo Nordisk A/S $NVO | Puzo Michael J significantly reduced its stake in Novo Nordisk A/S (NYSE:NVO) by 86.9% in Q3, now holding 5,775 shares v | [Link](https://longbridge.com/zh-HK/news/276447697.md) |
| Novo Nordisk Proposes Two Additional New Board Appointments | Danish pharmaceutical company Novo Nordisk is proposing three new appointments to its board of directors for the annual  | [Link](https://longbridge.com/zh-HK/news/276442777.md) |
| GLP-1 Anti-Obesity U.S. Drug Market In Four Charts | UBS analysts, led by Matthew Weston, have analyzed trends in the U.S. GLP-1 anti-obesity drug market, focusing on new-to | [Link](https://longbridge.com/zh-HK/news/276280378.md) |
| Novo Nordisk A/S - share repurchase programme | Novo Nordisk A/S has initiated a share repurchase programme of up to DKK 15 billion, starting from 4 February 2026. As o | [Link](https://longbridge.com/zh-HK/news/276056741.md) |
| Novo Nordisk board proposes re-election of Lars Rebien Sorensen as chair | Novo Nordisk board proposes re-election of Lars Rebien Sorensen as chair | [Link](https://longbridge.com/zh-HK/news/276440991.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。
